Developing a method to replace the hippocampus to treat drug-resistant epilepsy, neurological diseases, and aging.
NewBrain Biosciences is a pioneering force in Biotechnology Research, dedicated to advancing innovative solutions for complex neurological challenges. At the forefront of regenerative medicine, NewBrain Biosciences is focused on developing groundbreaking methods to address conditions such as drug-resistant epilepsy, neurological diseases, and the effects of aging. Through cutting-edge research and development, NewBrain Biosciences is committed to improving patient outcomes and transforming the landscape of brain health.
With a focus on replacing the hippocampus, NewBrain Biosciences is engineering human precursor brain tissue ex vivo using iPSC-derived cells and their normal extracellular environment. This novel approach holds immense potential for treating Alzheimer's disease and other age-related cognitive impairments. NewBrain Biosciences is dedicated to pushing the boundaries of scientific discovery and translating research breakthroughs into practical therapies.
NewBrain Biosciences is poised for significant growth and impact in the biotechnology sector. We invite the management team at NewBrain Biosciences to create a customized and exclusive company showcase and product listing on our platform to further enhance your visibility and commercial development.
Other organizations in the same industry
This company is also known as